Blueprint Medicines Corp (DELISTED) (BPMC:DL)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Jul 28, 16:00
Blueprint Medicines Market Cap: 8.361B for July 28, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 47.46B |
| TG Therapeutics, Inc. | 4.853B |
| AVITA Medical, Inc. | 118.92M |
| Ardelyx, Inc. | 1.640B |
| Bristol Myers Squibb Co. | 112.50B |
Market Cap Related Metrics
| PS Ratio | 14.76 |
| Price to Book Value | 24.44 |
| Price | 129.46 |
| Earnings Yield | -1.91% |